LumiraDx Limited announced the appointment of Veronique Ameye, the Company's Deputy Chief Executive Officer and General Counsel, to serve as the Company?s Chief Executive Officer and General Counsel, effective as of November 1, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0163 USD | -19.90% | -18.50% | -74.09% |
May. 20 | U.K. Competition Watchdog Weighs Potential Impact of Roche-LumiraDx | DJ |
Jan. 08 | Top Midday Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-74.09% | 7.3M | |
+10.91% | 226B | |
+14.77% | 198B | |
+19.69% | 142B | |
+30.25% | 111B | |
+2.13% | 65.26B | |
+16.64% | 54.36B | |
+4.96% | 50.94B | |
+9.50% | 44.8B | |
+4.30% | 36.8B |
- Stock Market
- Equities
- LMDXF Stock
- News LumiraDx Limited
- LumiraDx Limited Appoints Veronique Ameye as the Company?s Chief Executive Officer and General Counsel, Effective as of November 1, 2023